HCMT
NVAX icon

Highland Capital Management (Texas)’s Novavax NVAX Stock Holding History

Highland Capital Management (Texas)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-8,750
Closed -$551K – 217
2013
Q3 		$551K Buy
+8,750
New +$493K 0.04% 141

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Highland Capital Management (Texas)'s NVAX Position: Q4 2013 in Review

Highland Capital Management (Texas) sold out of Novavax (NVAX) in Q4 2013, closing a stake of 8,750 shares — an estimated $551K sold.

Highland Capital Management (Texas) first reported a position in NVAX in Q3 2013 and held it in 1 quarter. The position peaked at $551K in Q3 2013. 129 funds tracked by Wall St. Rank hold NVAX as of Q4 2013.

  • Highland Capital Management (Texas) reported no remaining Novavax position as of Q4 2013 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 8,750 Novavax shares in Q4 2013, an estimated $551K.
  • Highland Capital Management (Texas) first reported a position in Novavax in Q3 2013 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s Novavax position peaked at $551K in Q3 2013.
  • 129 funds tracked by Wall St. Rank held Novavax as of Q4 2013.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2013, filed 14 Feb 2014.